← Back to Patent Explorer
US4432971A Expired / Lapsed US ⏱️ 0.0 years remaining

Phosphonamidate compounds

Assignee: ER Squibb and Sons LLC
•
Filing: 1982-06-28
•
Granted: 1984-02-21
•
Expires: 2002-06-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Phosphonamidates of the formula <IMAGE> wherein X is a substituted or unsubstituted imino or amino acid or ester. These compounds possess angiotensin converting enzyme activity and are thus useful as hypotensive agents.

Inventors

  • 👤 Donald S. Karanewsky
  • 👤 Edward W. Petrillo, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 04:37
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/572; B; B01; B01J; B01J19/00; B01J19/18; B01J19/1806; C07F9/28; C07F9/38; C07F9/44; C07F9/4461; C07F9/4465; C07F9/568; C07F9/576; C07F9/59; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 233 words
A compound of the formula ##STR321## and a pharmaceutically acceptable salt thereof wherein: Y is oxygen or sulfur and the R 16 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a lower alkyl of 1 to 4 carbons or a di(lower alkyl of 1 to 4 carbons) substituent; R 1 is hydrogen, lower alkyl, or cycloalkyl; R 2 is hydrogen, lower alkyl, halo substituted lower alkyl, ##STR322## or R 1 and R 2 taken together are --(CH 2 ) n -- wherein n is an integer from 2 to 4; R 3 and R 6 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and ##STR323## wherein R 17 is hydrogen, lower alkyl, cycloalkyl, or phenyl, and R 18 is hydrogen, lower alkyl, lower alkoxy, phenyl or R 17 and R 18 taken together are ##STR324## R 13 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; r is an integer from 1 to 4; q is zero or an integer from 1 to 7; s is an integer from 1 to 8; and p is one, two or three provided that p is more than one only if R 13 is hydrogen, methyl, methoxy, chloro, or fluoro.
Claim 2
Dependent Claim 233 words
A compound of the formula ##STR321## and a pharmaceutically acceptable salt thereof wherein: Y is oxygen or sulfur and the R 16 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a lower alkyl of 1 to 4 carbons or a di(lower alkyl of 1 to 4 carbons) substituent; R 1 is hydrogen, lower alkyl, or cycloalkyl; R 2 is hydrogen, lower alkyl, halo substituted lower alkyl, ##STR322## or R 1 and R 2 taken together are --(CH 2 ) n -- wherein n is an integer from 2 to 4; R 3 and R 6 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and ##STR323## wherein R 17 is hydrogen, lower alkyl, cycloalkyl, or phenyl, and R 18 is hydrogen, lower alkyl, lower alkoxy, phenyl or R 17 and R 18 taken together are ##STR324## R 13 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; r is an integer from 1 to 4; q is zero or an integer from 1 to 7; s is an integer from 1 to 8; and p is one, two or three provided that p is more than one only if R 13 is hydrogen, methyl, methoxy, chloro, or fluoro.
Claim 3
Dependent Claim 206 words
A compound of claim 1 wherein: Y is oxygen or sulfur and the R 16 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a methyl or dimethyl substituent; R 1 is hydrogen or lower alkyl of 1 to 4 carbons; R 2 is hydrogen, lower alkyl of 1 to 4 carbons, CF 3 , or amino substituted lower alkyl of 1 to 4 carbons, or R 1 and R 2 taken together are --(CH 2 ) 3 --; R 21 is alkyl of 1 to 10 carbons, ##STR325## --(CH 2 ) q --cycloalkyl wherein cycloalkyl is of 5 or 6 carbons, ##STR326## R 3 and R 6 are independently selected from the group consisting of hydrogen, alkali metal salt, lower alkyl of 1 to 4 carbons, and ##STR327## R 17 is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, or cyclohexyl; R 18 is straight or branched chain lower alkyl of 1 to 4 carbons or phenyl; R 13 is hydrogen, methyl, methoxy, methylthio, chloro, bromo, fluoro, or hydroxy; q is zero or an integer from 1 to 4; and s is an integer from 1 to 8.
Claim 4
Dependent Claim 32 words
A compound of the claim 2 of the formula ##STR328## wherein: Y is oxygen or sulfur; t is two or three; and R 6 is hydrogen, ##STR329## or an alkali metal salt.
Claim 5
Dependent Claim 37 words
A compound of claim 3 wherein R 1 is hydrogen or methyl; R 2 is hydrogen, methyl, or --(CH 2 ) 4 --NH 2 ; and R 3 is hydrogen, ethyl, ##STR330## or an alkali metal salt.
Claim 6
Dependent Claim 15 words
A compound of claim 4 wherein R 21 is alkyl of 1 to 10 carbons.
Claim 7
Dependent Claim 33 words
A compound of claim 4 wherein R 21 is ##STR331## q is zero or an integer from 1 to 4, and R 13 is hydrogen, methyl, methoxy, methylthio, chloro, bromo, fluoro, or hydroxy.
Claim 8
Dependent Claim 9 words
A compound of claim 6 wherein X is ##STR332##
Claim 9
Dependent Claim 35 words
The compound of claim 7 wherein R 21 is ##STR333## R 1 is hydrogen; R 2 is methyl; R 3 and R 6 are the same and both are hydrogen or an alkali metal salt.
Claim 10
Dependent Claim 24 words
A compound of claim 4 wherein R 21 is --(CH 2 ) s --NH 2 and s is an integer from 1 to 8.
Claim 11
Dependent Claim 58 words
A composition useful for treating hypertension in a mammalian specie comprising a pharmaceutically acceptable carrier and an effective amount of a hypotensive agent or pharmaceutically acceptable salt thereof of the formula ##STR334## wherein R 1 , R 2 , R 3 , R 6 , R 21 , Y, and R 16 are as defined in claim 1.
Claim 12
Dependent Claim 9 words
The composition of claim 10 also including a diuretic.
Claim 13
Dependent Claim 21 words
The method of alleviating hypertension in a mammalian specie which comprises administering an effective amount of the composition of claim 10.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-02-20 1987-08-22 1988-02-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-02-20 1991-08-22 1992-02-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-02-20 1995-08-22 1996-02-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag